The China-based surgical robot manufacturer is gearing up for growth after receiving Europe’s CE mark last year for its ...

Johnson & Johnson’s filing comes a month after Medtronic gained U.S. clearance for its Hugo system as competition in the soft ...

Stereotaxis’ CEO said the company has been “hampered clinically, commercially and strategically” by its prior dependence on a ...

The company will use the money to try to establish its cuffless device as a go-to option for 24-hour blood pressure ...

The implantable lens maker said it would remain a stand-alone company after its shareholders turned down Alcon’s $1.6 billion ...

Under the agreement, the engineering partner will be responsible for a significant portion of the software development for ...

The chief medical officer is interested in an easier path to market for health screening features in wearable devices.

Executives at companies innovating a range of new robotic surgery platforms shared their progress and challenges in MedTech ...

Stanley Bergman has worked at Henry Schein for 45 years, more than 35 of which he spent as CEO, and was due to retire at the ...

The Sapien M3 device is the first approved mitral regurgitation treatment to use a transseptal approach, Edwards said.

The CMS created ACCESS to address barriers to care stemming from Medicare’s fee-for-service payment model. Rather than pay for specific services, Medicare will make recurring payments to healthcare ...

Sometimes, the line between medical and wellness products can blur. Regulators’ pushback on a blood pressure feature that Whoop incorporated into its wellness wristband illustrates the challenges ...